These three medtech companies are at the forefront of diabetes care.
News & Analysis: Tandem Diabetes Care
Find out what made these stocks miss out on a rally.
The business reported first-quarter 2019 earnings -- and more positive news since.
These two disruptive companies reported crazy-good top-line growth, but only one can be the winner.
TNDM earnings call for the period ending March 31, 2019.
Worries about what might happen with the U.S. healthcare system took a toll on the insulin-pump maker's share price.
Find out why our team of healthcare experts is laser-focused on these diabetes stocks right now.
Medical device stocks were hot in 2018. Here's which ones could sizzle in 2019.
Shares of the insulin pump maker have gained a whopping 1,490% over the last year.
Shares jumped after the company reported blowout fourth-quarter results and issued bullish guidance. Here's what investors need to know.